Avenza Pharmaceuticals Private Limited, a active private limited company, was established on 28 October 2015 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24132GJ2015PTC084912. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹12.61 Cr.
It upholds a compliant status. Employing 78 professional, Its leadership includes Dhruvalkumar Jayantilal Patel (Director), Vedant Nandkishore Maheshwari (Director), Dilavar Alibhai Abhavani (Director). It holds ₹58.40 Cr open charges and ₹2.38 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 705, Atlantis Heights, Sarabhai Compound, Vadi Wadi,, Vadodara, Gujarat, 390003.
U24132GJ2015PTC084912
084912
28 October 2015
₹13.00 Cr
₹12.61 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Avenza Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhruvalkumar Jayantilal Patel | Director | 28 Oct 2015 | Current |
| Vedant Nandkishore Maheshwari | Director | 28 Oct 2015 | Current |
| Dilavar Alibhai Abhavani | Director | 28 Oct 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avenza Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 172.44% increase. The company also saw a substantial fall in profitability, with a 295.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 445.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Avenza Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹584,000,000.00
₹2,380,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2021 | Others | ₹29.20 Cr | Open |
| 20 Dec 2020 | Others | ₹29.20 Cr | Open |
| 20 May 2022 | Indian Bank | ₹2.38 M | Satisfied |
Explore comprehensive loan charge details -
Avenza Pharmaceuticals has a workforce of 78 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avenza Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avenza Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 20 May 2022 via Charge ID 100590948 with Indian Bank was fully satisfied on 28 Aug 2025. was completed.
Avenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Avenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Others of Rs. 29.20 Cr registered on 06 Jan 2021 with Charge ID 100412050 was modified on 06 Oct 2022. was documented.
The activity A charge with Others of Rs. 29.20 Cr registered on 20 Dec 2020 with Charge ID 100412446 was modified on 06 Oct 2022. was completed.
Progress on A charge with Indian Bank amounted to Rs. 0.24 Cr with Charge ID 100590948 was registered on 20 May 2022. was documented.
The CIN of Avenza Pharmaceuticals Private Limited is U24132GJ2015PTC084912.
Avenza Pharmaceuticals Private Limited is headquartered at 705, Atlantis Heights, Sarabhai Compound, Vadi Wadi,, Vadodara, Gujarat, 390003.
Avenza Pharmaceuticals Private Limited was incorporated on 28 October 2015.
The current directors of Avenza Pharmaceuticals Private Limited are
The primary industry of Avenza Pharmaceuticals Private Limited is Trade.
Avenza Pharmaceuticals Private Limited is unlisted.
The authorized capital of Avenza Pharmaceuticals Private Limited is ₹13.00 Cr, and the paid-up capital is ₹12.61 Cr.
The compliance status of Avenza Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX